HOME >> MEDICINE >> NEWS
Now is a pivotal point in history to abolish state execution

This is a pivotal point in history for countries to consider evidence that demonstrates the barbarity of lethal injection and abolish state execution, states an editorial in this week's issue of The Lancet.

Last year The Lancet published a paper, which found that despite a theoretically lethal dose of the barbiturate thiopental, given before the injection of pancuronium to paralyse breathing muscles and potassium chloride to stop the heart, 21 of 49 executed US inmates had postmortem thiopental concentrations consistent with consciousness (See Lancet 2005; 365: 141214). Now, a Californian judge--Judge Jeremy Fogel--has ruled that the state must either rely solely on thiopental, or else have a qualified individual confirm unconsciousness before the injection of pancuronium and potassium chloride, in order to avoid excessive pain. As a result, Californian officials have had to postpone the execution of a convicted murderer by lethal injection after they were unable to find medical personnel willing to participate. Involvement in executions contradicts the principles of many professional organisations in the US, including the American Medical Association.

The Lancet comments: "This is a pivotal point in history. A moment when individuals, like Judge Fogel, and the anaesthetists who refused to participate, have given voice to their conscience. They have articulated the concerns of an increasing number of Americans, whose support for capital punishment has dropped from 80% to 64% in the past decade. It is a voice to be heeded. As Judge Fogel noted, the Eighth Amendment has been interpreted as prohibiting punishments that are 'incompatible with the evolving standards of decency that mark the progress of a maturing society'. In 2004, China, Iran, Vietnam, and the USA accounted for 97% of the world's executions. From which of these countries will a mature society take the lead, and abolish the atrocity of state execution?"


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
2-Mar-2006


Page: 1

Related medicine news :

1. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
2. Approval to start US BTT pivotal trial
3. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
4. New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial
5. Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
6. Metabolic syndrome points to heart health
7. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
8. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
9. System to pinpoint airline passengers who contaminate cabins
10. Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
11. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... 2017 , ... Floundering on New Year’s resolutions? Need an excuse to get ... reset. The U.S. Apple Association agrees and recommends starting each day with apples, ... to heart disease. , The U.S. Apple Association – which represents apple growers and ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... difference. Eden Activewear is a stand-out company for several differences from other mainstream ... only manufacture on demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . ...
(Date:1/17/2017)... Fla (PRWEB) , ... January 17, 2017 , ... SunView ... Excellence Award for Innovation of the Year. , Each year, Pink Elephant ... taken an innovative approach to address a specific business problem or opportunity. The award ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... as Palm Desert, is opening a new office in San Clemente, California this ... stimulation (dTMS) in Southern California, successfully treating individuals struggling with major depression. Depression ...
(Date:1/17/2017)... York (PRWEB) , ... January 17, 2017 , ... ... – SightMD – will lecture to primary eye care practitioners on the latest ... at the upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and Markets has announced the addition of the "Vital Signs Monitoring ... Industry Forecast, 2014-2022" report to their offering. ... Vital signs monitoring market size was worth $3,694 ... growing at a CAGR of 5.8% from 2016 to 2022. ... in global vital signs monitoring devices industry. The blood pressure monitoring devices ...
(Date:1/18/2017)... 2017   Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies to ... reported the Company,s operating results for 2016 and an ... the Company described in its recent 10-K filing with ... accomplishments. The Company,s contract laboratory completed its evaluation of ...
(Date:1/18/2017)... 18, 2017 Research and Markets has announced ... Market 2017-2021" report to their offering. ... The global CINV drugs market to ... Global Thoracic Surgery Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology:
Cached News: